NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









BioSimulytics

BioSimulytics

Private
DublinHealthcare & Life Scienceshttps://www.biosimulytics.com/

Last Round

Seed

Jan 21, 2025

Total Funding Raised

$3.46M

Company Overview

BioSimulytics is a biotechnology company that provides an AI-enhanced predictive platform for crystal structure prediction to assist pharmaceutical companies in drug development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Healthcare Analytics, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

molecular modelingcrystal structure predictionCSPpolymorph screeningin silico drug discoverycomputational chemistrydrug developmentAI drug discoverypharmaceutical R&Dlead optimizationquantum chemistrydigital chemistrypreclinical risk assessmenthigh-performance computingHPC

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BioSimulytics Comparables

Compare BioSimulytics with similar companies based on industry and business-model similarity.

BioSimulytics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
XtalPi
79%
Avant-garde Materials Simulation
78%
Cadence Design Systems
75%

BioSimulytics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 21, 2025
GrantJun 20, 2023
SeedSep 2, 2021
AcceleratorNov 28, 2019

Key People

Founding team and executive leadership

Peter F Doyle

CEO & Co-Founder

Founding Team

Johannes Eiglsperger

Chief Technology Officer

Executive Team

BioSimulytics Investors

Notable investors and investment history

BioSimulytics investors
InvestorRounds
European Innovation Council FundGrant
European Investment Bank GroupSeed
University College DublinAccelerator
Enterprise IrelandSeed, Accelerator

BioSimulytics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

BioSimulytics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about BioSimulytics's valuation, stock price, and market status.

Firmographic Details

HeadquartersDublin
Employee Range10
Year Founded2019
Last FundingJan 21, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.